Description

Seizmet GP 1 Glimepiride, Metformin SR , and Pioglitazone SEIZMET GP 1 are three medications often used in combination to manage type 2 diabetes. Each of these medications works in different ways to help control blood sugar levels: Glimepiride belongs to the sulfonylurea class of medications. It stimulates the pancreas to release more insulin, which helps lower blood sugar levels. Glimepiride is taken orally and can be used to enhance insulin secretion in people with type 2 diabetes. Metformin, in its sustained-release form, belongs to the biguanide class of medications. It primarily reduces the production of glucose in the liver and increases the sensitivity of muscle cells to insulin, allowing better glucose utilization. Metformin SR is taken orally and is commonly used as a first-line treatment for type 2 diabetes. Pioglitazone is a member of the thiazolidinedione (TZD) class of medications. It helps improve insulin sensitivity in muscle and fat tissues, allowing them to use glucose more effectively. Pioglitazone is also taken orally and is often prescribed in combination with other diabetes medications. Combining these three medications can provide a comprehensive approach to managing type 2 diabetes by addressing various aspects of glucose regulation. However, it's important to note that the specific combination and dosages should be determined by your healthcare provider based on your individual medical history, current blood sugar levels, and other factors. For further information please contact: info@sterispharma.com / contact@sterispharma.com call/whatsapp: 8209542042, 8955945010, 6377716668, 7976417364